Diabetes patients on colchicine after PCI show lower in-stent restenosis rates

04/29/2013 | Healio

Data on 196 diabetes patients who underwent percutaneous coronary intervention with a bare-metal stent showed those who received colchicine had an in-stent restenosis rate of 16%, compared with 33% in the placebo group. Colchicine-treated patients also had lower rates of late lumen loss than those in the control group, researchers wrote in the Journal of the American College of Cardiology.

View Full Article in:

Healio

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Sr. Principal OptoMechanical Engineer - 14000008M2
Abbott
San Jose, CA
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC
Sr. Principal Electrical Engineer - 14000008LR
Abbott
San Jose, CA